Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 6 Leukemia, Myeloid, Acute 3 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Locally Advanced Thyroid Gland Carcinoma 1 Liver Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 HCC 1 Fibrolamellar hepatocellular carcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

lenvatinib 1 atezolizumab 1 Tirapazamine 1 Sorafenib 1 Radiotherapy 1 Radiosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HCC × Sorafenib × Clear all

NCT05873244 2025-03-21

CXD101 in Immunotherapy-related Liver Cancer

Chinese University of Hong Kong

Phase 2 Recruiting

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡